Skip to main content
SpringerLink
Log in

RETRACTED ARTICLE: Fetal fibronectin (Quick Check fFN test) versus placental alpha microglobulin-1 (AmniSure test) for detection of premature rupture of fetal membranes

  • Maternal-Fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This article was retracted on 20 February 2024

This article has been updated

Abstract

Objectives

To compare accuracy of fetal fibronectin (fFN) versus placental alpha microglobulin-1 for detection of premature rupture of fetal membranes (PROM).

Methods

Two hundred and twenty pregnant women >34 and <37 weeks were included in this comparative prospective study and divided into two groups according to presence or absence of PROM. The diagnosis of PROM was based on patient’s history of sudden gush of water, pooling of amniotic fluid, positive ferning, positive nitrazine test, confirmed by visualization of fluid passing from the cervical canal and amniotic fluid index ≤5 cm measured by trans-abdominal ultrasound. Patients included in this study were examined by sterile speculum for visualization of membranes and for collection of samples (swabs) from posterior vaginal fornix.

Results

Sensitivity and specificity of AmniSure test to diagnose PROM were 97.3 and 98.2 %, respectively, compared with 94.5 and 89.1 %, respectively, for fFN test. Positive predictive value, negative predictive value, and accuracy of AmniSure test to diagnose PROM were 98.2, 97.3, and 97.7 %, respectively, compared with 89.7, 94.2, and 91.8 %, respectively, for fFN test. Predictive values and accuracy of fFN test to diagnose PROM were statistically insignificant compared with predictive values and accuracy of ferning, nitrazine and AmniSure tests.

Conclusion

fFN bedside test is better than nitrazine and ferning tests in detection of PROM, but is not suited for identification of clinically difficult cases with suspected PROM, because, it is influenceable and can give false-positive results in preterm labor, women >34 gestational weeks and after any vaginal manipulation without PROM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

References

  1. Medina TM, Hill DA (2006) The Florida Hospital Family Practice Residency Program, Orlando that begins: (preterm premature rupture of membranes). Am Fam Physician 73:659–664

    PubMed  Google Scholar 

  2. Furman B, Shoham-Vardi I, Bashiri A, Erez O, Mazor M (2000) Clinical significance and outcome of preterm prelabor rupture of membranes: population-based study. Eur J Obstet Gynecol Reprod Biol 92:209–216

    Article  CAS  PubMed  Google Scholar 

  3. Mercer BM, Goldenberg RL, Meis PJ, Moawad AH, Shellhaas C, Das A, Menard MK, Caritis SN, Thurnau GR, Dombrowski MP, Miodovnik M, Roberts JM, McNellis D (2000) The Preterm Prediction Study: prediction of preterm premature ruptures of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 183(3):738–745

    Article  CAS  PubMed  Google Scholar 

  4. Dilbaz B, Çaliskan E, Dilbaz S, Özdas E, Filiz T, Haberal A (2006) Use of insulin like growth factor binding protein-1 for diagnosis of ruptured fetal membranes in women with preterm labor. J Turk–Ger Gynecol Assoc 7(4):325–329

    Google Scholar 

  5. Lamont RF (2006) Setting up a preterm prevention clinic: a practical guide. BJOG 113(Suppl 3):86–92 (Review)

    Article  PubMed  Google Scholar 

  6. ACOG Committee on Practice Bulletins-Obstetrics (2007) ACOG practice bulletin no. 80: premature rupture of membranes. Clinical management guidelines for obstetrician–gynecologists. Obstet Gynecol 109:1007–1019

    Article  Google Scholar 

  7. Caughey AaronB, Robinson JulianN, Norwitz ErrolR (2008) Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol 1(1):11–22

    PubMed  PubMed Central  Google Scholar 

  8. Garite TJ (2001) Management of premature rupture of membranes. Clin Perinatol 28:837–847

    Article  CAS  PubMed  Google Scholar 

  9. Lodeiro JG, Hsieh KA, Byers JH, Feinstein SJ (1989) The fingerprint, a false-positive fern test. Obstet Gynecol 73:873–874

    CAS  PubMed  Google Scholar 

  10. Rosemond RL, Lombardi SJ, Boehm FH (1990) Ferning of amniotic fluid contaminated with blood. Obstet Gynecol 75:338–340

    CAS  PubMed  Google Scholar 

  11. de Haan HH, Offermans PM, Smits F, Schouten HJ, Peeters LL (1994) Value of the Fern test to confirm or reject the diagnosis of ruptured membranes in modest in non-laboring women presenting with non-specific vaginal fluid loss. Am J Perinatol 11:46–50

    Article  PubMed  Google Scholar 

  12. Jeurgens-Borst AJ, Bekkers RL, Sporken JM, van der Berg PP (2002) Use of insulin like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Eur J Obstet Gynecol Reprod Biol 102:11–14

    Article  CAS  PubMed  Google Scholar 

  13. Buyukbayrak EE, Turan C, Unal O, Dansuk R, Cengizoglu B (2004) Diagnostic power of the vaginal washing-fluid prolactin assay as an alternative method for the diagnosis of premature rupture of membranes. J Matern Fetal Neonatal Med 15:120–125

    Article  CAS  PubMed  Google Scholar 

  14. Abdelazim IA, Makhlouf HH (2013) Placental alpha microglobulin-1 (AmniSure test) versus insulin-like growth factor binding protein-1 (Actim PROM test) for detection of premature rupture of fetal membranes. J Obstet Gynaecol Res 9(6):1129–1136

    Article  Google Scholar 

  15. Abdelazim IA (2013) Insulin-like growth factor binding protein-1 (Actim PROM test) for detection of premature rupture of fetal membranes. J Obstet Gynaecol Res. doi:10.1111/jog.12296

  16. Erdemoglu E, Mungan T (2004) Significance of detecting insulin like growth factor binding protein-1 in cervicovaginal secretions: comparison with nitrazine test and amniotic fluid volume assessment. Acta Obstet Gynecol Scand 83:622–626

    Article  PubMed  Google Scholar 

  17. Akercan F, Cirpan T, Kazandi M, Terek MC, Mgoyi L, Ozkinay E (2005) The value of the insulin like growth factor binding protein-1 in the cervico-vaginal secretion detected by immunochromatographic dipstick test in the prediction of delivery in women with clinically unconfirmed premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 121:159–163

    Article  CAS  PubMed  Google Scholar 

  18. Kim YH, Park YW, Kwon HS, Kwon JY, Kim BJ (2005) Vaginal fluid beta human chorionic gonadotropin in level in the diagnosis of premature rupture of membranes. Acta Obstet Gynecol Scand 84:802–805

    PubMed  Google Scholar 

  19. Cooper AL, Stephen T, Vermillion M, David E (2004) Qualitative human chorionic gonadotropin testing of cervicovaginal washings for the detection of preterm premature rupture of membranes. Am J Obstet Gynecol 191:593–597

    Article  CAS  PubMed  Google Scholar 

  20. Esim E, Turan C, Uanl O, Dansuk R, Cengizglu B (2003) Diagnosis of premature rupture of membranes by identification of beta-HCG in vaginal washing fluid. Eur J Obstet Gynecol Reprod Biol 107:37–40

    Article  CAS  PubMed  Google Scholar 

  21. Tagore S, Kwek K (2010) Comparative analysis of insulin-like growth factor binding protein-1 (IGFBP-1), placental alpha microglobulin-1 (PAMG-1) and nitrazine test to diagnose premature rupture of membranes in pregnancy. J Perinat Med 38:609–612

    Article  PubMed  Google Scholar 

  22. Chen FC, Dudenhausen JW (2008) Comparison of two rapid strip tests based on IGFBP-1 and PAMG-1 for the detection of amniotic fluid. Am J Perinatol 25:243–246

    Article  CAS  PubMed  Google Scholar 

  23. Birkenmaier A, Ries JJ, Kuhle J, Bürki N, Lapaire O, Hösli I (2012) Placental a-microglobulin-1 to detect uncertain rupture of membranes in a European cohort of pregnancies. Arch Gynecol Obstet 285:21–25

    Article  CAS  PubMed  Google Scholar 

  24. Boltovskaia MN, Zaraĭskiĭ EI, Fuks BB, Sukhikh GT, Kalafati TI, Starosvetskaia NA, Nazimova SV, Marshitskaia MI, Likharev VA (1991) Histochemical and clinical-diagnostic study of placental alpha 1-microglobulin using monoclonal antibodies. Biull Eksp Biol Med 112(10):397–400 (article in Russian)

    CAS  PubMed  Google Scholar 

  25. Abdelazim IbrahimA, Makhlouf HananH (2012) Placental alpha microglobulin-1 (AmniSure test) for detection of premature rupture of fetal membranes. Arch Gynecol Obstet 285:985–989

    Article  PubMed  Google Scholar 

  26. El-Messidi A, Cameron A (2010) Diagnosis of premature rupture of membranes: inspiration from the past and insights for the future. J Obstet Gynaecol Can 32(6):561–569

    Article  PubMed  Google Scholar 

  27. Di Renzo GC, Roura LC, Facchinetti F, Antsaklis A, Breborowicz G, Gratacos E, Husslein P, Lamont R, Mikhailov A, Montenegro N, Radunovic N, Robson M, Robson SC, Sen C, Shennan A, Stamatian F, Ville Y (2011) Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes and preventive tools for preterm birth. J Matern Fetal Neonatal Med 24(5):659–667

    Article  PubMed  PubMed Central  Google Scholar 

  28. Abdelazim IA (2013) Fetal fibronectin (Quick Check fFN test) for detection of premature rupture of fetal membranes. Arch Gynecol Obstet 287(2):205–210

    Article  CAS  PubMed  Google Scholar 

  29. Eriksen NL, Parisi VM, Daoust S, Flamm B, Garite TJ, Cox SM (1992) Fetal fibronectin: a method for detecting the presence of amniotic fluid. Obstet Gynecol 80(3 Pt1):451–454

    CAS  PubMed  Google Scholar 

  30. Stafford IP, Garite TJ, Dildy GA, Colon-Lucach A, Williams CA, Bobritchi B, Lapointe J, Bloch DA (2008) A comparison of speculum and nonspeculum collection of cervicovaginal specimens for fetal fibronectin testing. Am J Obstet Gynecol 199(2):131.e1–131.e4

    Article  PubMed  Google Scholar 

  31. García Alonso LA, Jiménez SG, Ayala Méndez JA, Izquierdo Puente JC, Barahona BE (2002) Clinical usefulness of fetal fibronectin (fFN) expression in cervico-vaginal secretions (CVS). Ginecol Obstet Mex 70(8):379–384 (article in Spanish)

    PubMed  Google Scholar 

  32. Skoll A, St Louis P, Amiri N, Delisle MF, Lalji S (2006) The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients. JOGC 28(3):206–213

    PubMed  Google Scholar 

  33. Schmitz T, Maillard F, Bessard-Bacquaert S, Kayem G, Fulla Y, Cabrol D, Goffinet F (2006) Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol 194(1):138–143

    Article  CAS  PubMed  Google Scholar 

  34. Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM (2009) Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol 114(3):631–640

    Article  PubMed  Google Scholar 

  35. Wilms FF, van Stralen G, Porath MM, Papatsonis DN, Oei SG, Mol BW, Scherjon S (2009) Predicating imminent preterm labour based on a determination of foetal fibronectin in a vaginal smear. Ned Tijdschr Geneeskd 153:B398

    PubMed  Google Scholar 

  36. Cousins LM, Smok DP, Lovett SM, Poeltler DM (2005) AmniSure placental alpha microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatol 22:317–320

    Article  PubMed  Google Scholar 

  37. Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK (2007) Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol 109:634–640

    Article  CAS  PubMed  Google Scholar 

  38. Cousins LM, Smoke DP, Lovett SM, Poeltler DM (2005) AmniSure, placental alpha microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatol 22(6):317–320

    Article  PubMed  Google Scholar 

  39. Gronowski AM, Grenache DG, Markenson G, Weiner R, Demers LM, St. Louis P (2007) Reproductive testing. In: Nichols JH (ed) The National Academy of Clinical Biochemistry presents Laboratory Medicine Practice Guidelines: evidence-based practice for point-of-care testing. AACC Press, Washington, DC, pp 135–143

    Google Scholar 

  40. Smith V, Devane D, Begley CM, Clarke M, Higgins S (2007) A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth. Eur J Obstet Gynecol Reprod Biol 133:134–142

    Article  CAS  PubMed  Google Scholar 

  41. Nisell H, Hagskog K, Westgren M (1996) Assessment of fetal fibronectin in cervical secretion in cases of equivocal rupture of the membranes at term. Acta Obstet Gynecol Scand 75(2):132–134

    Article  CAS  PubMed  Google Scholar 

  42. Salfelder A, Kagerah M, Nugent W, Hickl EJ (1992) Detection of fibronectin for confirming the diagnosis of premature rupture of fetal membranes. Geburtshilfe Frauenheilkd 52(12):730–733 (article in Germany)

    Article  CAS  PubMed  Google Scholar 

  43. Gu H, Ding Y, Li Y (1995) Fetal fibronectin diagnosis of premature rupture of the amniotic membranes. Zhonghua Fu Chan Ke Za Zhi 30(9):533–535 (article in Chinese)

    CAS  PubMed  Google Scholar 

  44. Gaucherand P, Guibaud S, Awada A, Rudigoz RC (1995) Comparative study of three amniotic fluid markers in premature rupture of membranes: fetal fibronectin, alpha-fetoprotein, diamino-oxidase. ACIU Obstet Gynecol Scand 74:118–121

    Article  CAS  Google Scholar 

Download references

Conflict of interest

Authors declare that no actual or potential conflict of interest in relation to this article exists.

Funding

The research was funded by the authors.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt

    Ibrahim A. Abdelazim, Khaled M. Abdelrazak, Mohamed Al-kadi, Amr H. Yehia & Amr F. Abdulkareem

  2. Department of Obstetrics and Gynecology, Ahmadi Hospital, Kuwait Oil Company (KOC), P.O. Box 9758, 61008, Ahmadi, Kuwait

    Ibrahim A. Abdelazim & Amr F. Abdulkareem

Authors
  1. Ibrahim A. Abdelazim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khaled M. Abdelrazak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamed Al-kadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amr H. Yehia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amr F. Abdulkareem
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ibrahim A. Abdelazim.

About this article

Cite this article

Abdelazim, I.A., Abdelrazak, K.M., Al-kadi, M. et al. RETRACTED ARTICLE: Fetal fibronectin (Quick Check fFN test) versus placental alpha microglobulin-1 (AmniSure test) for detection of premature rupture of fetal membranes. Arch Gynecol Obstet 290, 457–464 (2014). https://doi.org/10.1007/s00404-014-3225-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-014-3225-5

Keywords

Search

Navigation